Sherwin Wilk
#158,113
Most Influential Person Now
Sherwin Wilk's AcademicInfluence.com Rankings
Sherwin Wilkbiology Degrees
Biology
#12308
World Rank
#15776
Historical Rank
Molecular Biology
#1982
World Rank
#2014
Historical Rank
Biochemistry
#2088
World Rank
#2232
Historical Rank
Download Badge
Biology
Why Is Sherwin Wilk Influential?
(Suggest an Edit or Addition)Sherwin Wilk's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Evidence that Pituitary Cation‐Sensitive Neutral Endopeptidase Is a Multicatalytic Protease Complex (1983) (307)
- Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression (1998) (279)
- Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B. (1996) (274)
- Cation‐Sensitive Neutral Endopeptidase: Isolation and Specificity of the Bovine Pituitary Enzyme (1980) (274)
- Amphetamine psychosis: Behavioral and biochemical aspects (1974) (213)
- Ubiquitin-independent proteolytic functions of the proteasome. (2003) (207)
- A New Inhibitor of the Chymotrypsin‐Like Activity of the Multicatalytic Proteinase Complex (20S Proteasome) Induces Accumulation of Ubiquitin‐Protein Conjugates in a Neuronal Cell (1994) (192)
- PURIFICATION AND PROPERTIES OF A PROLYL ENDOPEPTIDASE FROM RABBIT BRAIN (1979) (169)
- Minireview prolyl endopeptidase (1983) (160)
- Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients. (1975) (157)
- Inhibition of Rabbit Brain Prolyl Endopeptidase by N‐Benzyloxycarbonyl‐Prolyl‐Prolinal, a Transition State Aldehyde Inhibitor (1983) (153)
- Ubiquitin-mediated proteolysis centers in HeLa cells: indication from studies of an inhibitor of the chymotrypsin-like activity of the proteasome. (1996) (148)
- Amphetamine psychosis: behavioral and biochemical aspects. (1974) (136)
- Cerebrospinal Fluid Levels of MHPG in Affective Disorders (1972) (118)
- Dentate granule neuron apoptosis and glia activation in murine hippocampus induced by trimethyltin exposure (2001) (108)
- gamma-Glutamyl dopa: a kidney-specific dopamine precursor. (1978) (107)
- Determination of urinary 3-methoxy-4-hydroxyphenyl-ethylene glycol by gas-liquid chromatography and electron capture detection. (1967) (103)
- Differential inhibition of aminopeptidase A and aminopeptidase N by new beta-amino thiols. (1994) (100)
- Modulation of endomorphin-2-induced analgesia by dipeptidyl peptidase IV (1999) (100)
- Metabolism of vasoactive peptides by plasma and purified renal aminopeptidase M. (1990) (97)
- Purification, Characterization, and Cloning of a Cytosolic Aspartyl Aminopeptidase* (1998) (92)
- Comparison of the Effect of Calpain Inhibitors on Two Extralysosomal Proteinases: The Multicatalytic Proteinase Complex and m‐Calpain (1994) (90)
- Prolyl endopeptidase. (1983) (86)
- CATECHOLAMINES AND AFFECTIVE DISORDERS REVISED: A CRITICAL ASSESSMENT (1974) (85)
- Differential sensitivity of two dopaminergic structures in rat brain to haloperidol and to clozapine. (1975) (83)
- Delineation of a Particulate Thyrotropin‐Releasing Hormone‐Degrading Enzyme in Rat Brain by the Use of Specific Inhibitors of Prolyl Endopeptidase and Pyroglutamyl Peptide Hydrolase (1986) (82)
- Oligomers of Mutant Glial Fibrillary Acidic Protein (GFAP) Inhibit the Proteasome System in Alexander Disease Astrocytes, and the Small Heat Shock Protein αB-Crystallin Reverses the Inhibition* (2010) (82)
- Evaluation of dopamine metabolism in rat striatum by a gas chromatographic technique. (1975) (81)
- Cerebrospinal fluid MHPG. An assessment of norepinephrine metabolism in affective disorders. (1973) (79)
- Excretion of catecholamine catabolites by normal children. (1968) (75)
- Localization of immunoreactive glutamyl aminopeptidase in rat brain. II. Distribution and correlation with angiotensin II (1993) (73)
- Derivatization and gas chromatographic determination of some biologically important acids in cerebrospinal fluid. (1974) (72)
- Serine and cysteine proteinase inhibitors prevent nitric oxide production by activated macrophages by interfering with transcription of the inducible NO synthase gene. (1995) (71)
- Subcellular Distribution of Prolyl Endopeptidase and Cation‐Sensitive Neutral Endopeptidase in Rabbit Brain (1982) (66)
- Glutamyl aminopeptidase (aminopeptidase A), the BP-1/6C3 antigen (1993) (62)
- Proteasome activator (PA28) subunits, α, β and γ (Ki antigen) in NT2 neuronal precursor cells and HeLa S3 cells (1998) (61)
- S 17092-1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidase. (1999) (61)
- Loss of dipeptidylpeptidase IV activity in chronic rhinosinusitis contributes to the neurogenic inflammation induced by substance P in the nasal mucosa (2002) (59)
- Pyroglutamyl peptidase type I from Trypanosoma brucei: a new virulence factor from African trypanosomes that de-blocks regulatory peptides in the plasma of infected hosts. (2006) (59)
- Prolyl Endopeptidase: Inhibition In Vivo by N‐Benzyloxycarbonyl‐Prolyl‐Prolinal (1984) (59)
- Neuropeptide-specific peptidases: does brain contain a specific TRH-degrading enzyme? (1986) (58)
- PLASMA CLEARANCE OF DL-BETA-H3-NOREPINEPHRINE IN NORMAL HUMAN SUBJECTS AND PATIENTS WITH ESSENTIAL HYPERTENSION. (1964) (58)
- Determination of 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) in cerebrospinal fluid. (1971) (58)
- Phosphorylation of the multicatalytic proteinase complex from bovine pituitaries by a copurifying cAMP-dependent protein kinase. (1990) (57)
- Preparation and studies on the characterization of sheep brain glutamine synthetase. (1969) (57)
- A quantitative assay for vanillylmandelic acid (VMA) by gas-liquid chromatography. (1965) (53)
- Aminoacylpyrrolidine-2-nitriles: potent and stable inhibitors of dipeptidyl-peptidase IV (CD 26). (1995) (53)
- Simultaneous determination of 3,4-dihydroxyphenylacetic acid and homovanillic acid in milligram amounts of rat striatal tissue by gas-liquid chromatography. (1974) (52)
- Pyroglutamyl peptidase II, a thyrotropin releasing hormone degrading enzyme: purification and specificity studies of the rabbit brain enzyme (1989) (50)
- Aminopeptidase A antiserum inhibits intracerebroventricular angiotensin II-induced dipsogenic and pressor responses (1997) (48)
- Investigation of the active site of aminopeptidase A using a series of new thiol-containing inhibitors. (1994) (48)
- Synthetic inhibitors of the multicatalytic proteinase complex (proteasome). (1993) (48)
- Separation of cathepsin A-like enzyme and the proteasome: evidence that lactacystin/beta-lactone is not a specific inhibitor of the proteasome. (2000) (47)
- Rat kidney glutamyl aminopeptidase (aminopeptidase A): molecular identity and cellular localization. (1994) (46)
- Proteasome Contributes to the α‐Secretase Pathway of Amyloid Precursor Protein in Human Cells (1997) (45)
- Pyroglutamyl peptidase II inhibition specifically increases recovery of TRH released from rat brain slices (1989) (43)
- The anti-monoamine oxidase effects of furazolidone. (1967) (43)
- Enzymatic changes of the bovine pituitary multicatalytic proteinase complex, induced by magnesium ions. (1992) (41)
- Protein Kinase A Phosphorylation of the Proteasome: A Contribution to the α‐Secretase Pathway in Human Cells (1996) (41)
- Properties of the Nuclear Proteasome Activator PA28γ (REGγ) (2000) (41)
- Constitutive and Protein Kinase C‐Regulated Secretory Cleavage of Alzheimer's β‐Amyloid Precursor Protein: Different Control of Early and Late Events by the Proteasome (1997) (40)
- Pyroglutamyl diazomethyl ketone: potent inhibitor of mammalian pyroglutamyl peptide hydrolase. (1985) (40)
- Localization of immunoreactive glutamyl aminopeptidase in rat brain. I. Association with cerebral microvessels (1993) (40)
- Electron Capture Properties of Halogenated Amine Derivatives (1966) (39)
- JLK isocoumarin inhibitors: Selective γ‐secretase inhibitors that do not interfere with notch pathway in vitro or in vivo (2003) (38)
- The occurrence of free L‐pyrrolidone carboxylic acid in body fluids and tissues (1973) (37)
- Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitors. (2006) (37)
- Synergistic antitumor effects of a selective proteasome inhibitor and TNF in mice. (2000) (36)
- An inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces arrest in G2-phase and metaphase in HeLa cells. (1996) (36)
- 6-Hydroxydopamine but not 1-methyl-4-phenylpyridinium abolishes α-synuclein anti-apoptotic phenotype by inhibiting its proteasomal degradation and by promoting its aggregation. (2006) (35)
- Regulation of Thyrotropin Releasing Hormone Degrading Enzymes in Rat Brain and Pituitary by L‐ 3,5,3′‐Triiodothyronine (1989) (35)
- Specific inhibitors of pyroglutamyl peptidase I and prolyl endopeptidase do not change the in vitro release of TRH or its content in rodent brain (1987) (35)
- Evaluation of the role of prolyl endopeptidase and pyroglutamyl peptidase I in the metabolism of LHRH and TRH in brain (1990) (34)
- A novel chymotrypsin-like component of the multicatalytic proteinase complex optimally active at acidic pH. (1995) (30)
- Synthetic peptide-based activators of the proteasome (1997) (30)
- 5-Oxoprolinal: transition-state aldehyde inhibitor of pyroglutamyl-peptide hydrolase. (1985) (30)
- 3,4-dichloroisocoumarin-induced activation of the degradation of beta-casein by the bovine pituitary multicatalytic proteinase complex. (1992) (29)
- Properties of the nuclear proteasome activator PA28gamma (REGgamma). (2000) (29)
- Inhibition of Prolyl Oligopeptidase by Fmoc‐Aminoacylpyrrolidine‐2‐Nitriles (1996) (28)
- Proteasome activator (PA28) subunits, alpha, beta and gamma (Ki antigen) in NT2 neuronal precursor cells and HeLa S3 cells. (1998) (28)
- Gas Chromatographic Determination of Dopamine at the Nanogram Level (1967) (28)
- Identification of histidine residues important in the catalysis and structure of aspartyl aminopeptidase. (2002) (28)
- Studies on the subunit structure of ovine brain glutamine synthetase. (1969) (27)
- Human norepinephrine metabolism. Its evaluation bydministration of tritiated norepinephrine. (1971) (26)
- COLLABORATIVE PSYCHOPHARMACOLOGIC STUDIES EXPLORING CATECHOLAMINE METABOLISM IN PSYCHIATRIC DISORDERS (1974) (26)
- The effect of inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase on TRH degradation in rat serum. (1985) (25)
- Inhibition of angiotensin III formation by thiol derivatives of acidic amino acids (1990) (25)
- Purification procedures determine the proteasome activation properties of REGγ (PA28γ) (2004) (25)
- Multicatalytic proteinase complex or multicatalytic proteinase: a high-Mr endopeptidase (1988) (24)
- Dopamine metabolism in the nucleus accumbens: the effect of clozapine. (1976) (23)
- Determination of probenecid in small volumes of cerebrospinal fluid 1 (1973) (22)
- Chemical modification of the bovine pituitary multicatalytic proteinase complex by N-acetylimidazole. Reversible activation of casein hydrolysis. (1991) (21)
- Striatal DOPAC elevation predicts antipsychotic efficacy of metoclopramide. (1979) (21)
- Inhibitors of an enkephalin degrading membrane-bound metalloendopeptidase: analgesic properties and effects on striatal enkephalin levels. (1984) (20)
- Determination of pyrrolidone carboxylate and γ-glutamyl amino acids by gas chromatography (1975) (20)
- Occurrence of pyroglutamyl peptidase II, a specific TRH degrading enzyme in rabbit retinal membranes and in human retinoblastoma cells (1988) (18)
- Pyroglutamyl peptidase-II ("thyroliberinase") activity in human serum: influence of weight and thyroid status. (1995) (18)
- A microquantitative technique for the detection of some biologically important amines by gas-liquid chromatography☆ (1964) (18)
- Catabolism of endogenous and overexpressed APH1a and PEN2: evidence for artifactual involvement of the proteasome in the degradation of overexpressed proteins. (2006) (18)
- Dopamine metabolites in human brain (1978) (18)
- The effect of antipsychotic drugs and their clinically inactive analogs on dopamine metabolism. (1977) (17)
- Cleavage of Pro-X and Glu-X bonds catalyzed by the branched chain amino acid preferring activity of the bovine pituitary multicatalytic proteinase complex (20S proteasome). (1996) (16)
- Dopamine metabolism in the tuberculum olfactorium. (1975) (16)
- Properties of the beta subunit of the proteasome activator PA28 (11S REG). (2000) (15)
- The effect of typical and atypical neuroleptics on binding of [3H]spiroperidol in calf caudate. (1980) (15)
- Perlapine and dopamine metabolism: prediction of antipsychotic efficacy. (1977) (15)
- Absence of 3-methoxy-4-hydroxyphenylethanol in brain. (1973) (15)
- Inhibition of human immunodeficiency virus type 1 infection in a T-cell line (CEM) by new dipeptidyl-peptidase IV (CD26) inhibitors. (1997) (14)
- Purification procedures determine the proteasome activation properties of REG gamma (PA28 gamma). (2004) (14)
- Peptide-degrading enzymatic activities in GH3 cells and rat anterior pituitary homogenates. (1984) (14)
- Antinociceptive and behavioral activation responses elicited by d-Pro2-Endomorphin-2 in the ventrolateral periaqueductal gray are sensitive to sex and gonadectomy differences in rats☆ (2000) (13)
- Assessment of cerebrospinal fluid levels of dopamine metabolites by gas chromatography (1975) (12)
- Changes in proteasome expression and activity during differentiation of neuronal precursor NTera 2 clone D1 cells (1999) (12)
- Apoptosis induced in L1210 leukaemia cells by an inhibitor of the chymotrypsin-like activity of the proteasome (2004) (12)
- Clozapine concentrations in brain regions: relationship to dopamine metabolite increase. (1978) (11)
- Studies on the detection of 3-methoxy-4-hydroxyphenylethanol in human cerebrospinal fluid. (1971) (11)
- Evidence for regulation of a thyrotropin-releasing hormone degradation pathway in GH3 cells. (1986) (11)
- On the measurement of 5‐hydroxyindoleacetic acid in cerebrospinal fluid 1 (1972) (10)
- The Use of Analogues of TRH to Probe the Specificity of Pyroglutamyl Peptidase II a (1989) (10)
- Proteasome contributes to the alpha-secretase pathway of amyloid precursor protein in human cells. (1997) (10)
- Production and properties of a recombinant soluble form of aminopeptidase A. (1998) (10)
- Thiethylperazine; clinical antipsychotic efficacy and correlation with potency in predictive systems. (1978) (10)
- Regulation of a thyrotropin-releasing hormone-degrading enzyme in GH3 cells: induction of pyroglutamyl peptidase I by 3,5,3'-triiodothyronine. (1987) (10)
- Inhibition of proteasome, apoptosis and sensitization to tumour necrosis factor alpha: do they always go together? (1999) (9)
- JLK inhibitors: isocoumarin compounds as putative probes to selectively target the gamma-secretase pathway. (2005) (9)
- Rabbit Brain Pyroglutamyl Peptidase II, A Membrane-bound TRH Degrading Enzyme.: Purification and Specificity Studies (1989) (9)
- Properties of the Proteasome Activator Subunit PA28α and its Des-Tyrosyl Analog (1998) (9)
- Rapid inactivation and phosphorylation of pyroglutamyl peptidase II in Y-79 human retinoblastoma cells after exposure to phorbol ester. (1990) (9)
- Quantitation and Regulation of Pyroglutamyl Peptidase II Messenger RNA Levels in Rat Tissues and GH3 Cells (1998) (9)
- Dissociation of native octameric brain glutamine synthetase to a tetramer by treatment with N-acetylimidazole. (1970) (8)
- Changes in the structure and catalytic activities of the bovine pituitary multicatalytic proteinase complex following dialysis. (1993) (8)
- METABOLISM OF BIOGENIC AMINES IN THE CENTRAL NERVOUS SYSTEM OF MAN (1976) (8)
- VMA IN SPINAL FLUID: EVALUATION OF THE PATHWAYS OF CEREBRAL CATECHOLAMINE METABOLISM IN MAN (1974) (8)
- Inhibitors of TRH‐Degrading Enzymes a (1989) (7)
- Chloride channel ClC-5 binds to aspartyl aminopeptidase to regulate renal albumin endocytosis. (2015) (7)
- Metabolites of monoamines in urine and cerebrospinal fluid, after large dose amphetamine administration (2004) (7)
- The effect of probenecid and large dose amphetamine administration on cerebrospinal fluid homovanillic acid. (1974) (6)
- Modulation of the PA28α–20S Proteasome Interaction by a Peptidyl Alcohol☆☆☆ (1999) (6)
- Dissociation and reassociation of the bovine pituitary multicatalytic proteinase complex. (1994) (6)
- High-performance liquid chromatographic separation of renin-angiotensin system peptides and most of their metabolic fragments. (2002) (6)
- Inhibitors of TRH-degrading enzymes. (1989) (6)
- γ-glutamyl dopa and γ-glutamyl dopamine: Effect of plasma glucose levels (1979) (6)
- A combination of retinoic acid and proteasome inhibitors for the treatment of leukemias is potentially dangerous. (1999) (6)
- Purification of the Eukaryotic 20S Proteasome (2001) (5)
- Cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylethylene glycol in Parkinsonism before and after treatment with L-dopa. (1971) (5)
- Probing the specificity of the bovine pituitary multicatalytic proteinase complex by inhibitors, activators, and by chemical modification. (1991) (5)
- Increased local vascular endothelial growth factor expression associated with antitumor activity of proteasome inhibitor (2004) (5)
- Teaching resources. Apoptosis. (2005) (4)
- The modification of L-dopa induced dyskinesias in the monkey by unilateral nigral lesions. (1973) (4)
- Contribution of the proteasome to the alpha-secretase pathway in Alzheimer's disease. (1997) (4)
- Rabbit Brain Pyroglutamyl Peptidase II, A Membrane‐bound TRH Degrading Enzyme (1989) (4)
- Inhibition of pyroglutamyl peptidase II synthesis by phorbol ester in the Y-79 retinoblastoma cell. (1991) (4)
- Assessment of the role of TRH in the release of [3H]-dopamine from rat nucleus accumbens-lateral septum slices (1993) (3)
- Investigation of the Active Site of Aminopeptidase A Using a Series of New Thiol‐Containing Inhibitors. (2010) (3)
- An internal standard for the colorimetric determination of monoamine oxidase activity (1961) (3)
- 6-Hydroxydopamine but Not 1-Methyl-4-phenylpyridinium Abolishes α-Synuclein Anti-apoptotic Phenotype by Inhibiting Its Proteasomal Degradation and by Promoting Its Aggregation* (2006) (3)
- Properties of the proteasome activator subunit PA28 alpha and its des-tyrosyl analog. (1998) (3)
- CEREBROSPINAL FLUID LEVELS OF 5-HYDROXYINDOLEACETIC ACID IN PSYCHIATRIC DISORDERS: A CRITICAL ASSESSMENT (1973) (3)
- Sodium butyrate induces pyroglutamyl peptidase I and decreases thyrotropin-releasing hormone receptors in GH3 cells. (1989) (3)
- [3H]dihydroergocryptine binding to bovine striatal membranes defined by a low d-butaclamol concentration: antagonism by substituted benzamides. (1981) (2)
- Exploration of affective illness. (1976) (2)
- Low-dose nitrendipine in mild hypertension: a double-blind, placebo-controlled, comparative study. (1991) (2)
- Study on the Putative Contribution of Caspases and the Proteasome to the Degradation of Aph-1a and Pen-2 (2007) (2)
- Proteasomes. Multicatalytic proteinase complexes. (1994) (2)
- Modulation of the PA28alpha-20S proteasome interaction by a peptidyl alcohol. (1999) (2)
- A comparison of the effect of substituted benzamides in radioreceptor binding assays with their effects on brain dopaminergic systems in vivo. (1982) (2)
- Modulators of the activation of the proteasome by PA28 (11S Reg) (1999) (2)
- Biphasic down regulation of pyroglutamyl peptidase ii a trh degrading enzyme by protein kinase c (1990) (1)
- γ-GLUTAMYL DOPA AND γ-GLUTAMYL DOPAMINE AS KIDNEY SPECIFIC PRO-DRUGS (1979) (1)
- A study of spinal fluid homovanillic acid (HVA) in patients with diseases of the nervous system. (1972) (1)
- 1453 – METABOLISM OF BIOGENIC AMINES IN THE CENTRAL NERVOUS SYSTEM OF MAN (1977) (1)
- Apoptosis (2005) (1)
- The differential effects of morphine, oxotremorine and antipsychotic drugs on DOPAC concentrations in rat brain (1980) (1)
- DOPAMINE AND SCHIZOPHRENIA (1977) (1)
- Electron capture properties of halogenated amine derivatives / by Donald D. Clarke, Sherwin Wilk, and Stanley E. Gitlow (1966) (0)
- STRUCTURE SENSITIVITY RELATIONSHIPS IN ELECTRON CAPTURE DETECTION. APPLICATIONS TO THE ASSAY OF CATECHOLAMINES AND THEIR METABOLITES (1967) (0)
- Teaching resources. Proteases and signaling. (2005) (0)
- Purification procedures determine the proteasome activation properties of REG c (PA28 c ) (2004) (0)
- 280 – Aspartyl aminopeptidase (2004) (0)
- Plasma Clearance ofdl-0-H3-Norepinephrine inNormal Human Subjects andPatients withEssential Hypertension * (2009) (0)
- 322 – Alanine carboxypeptidase (2004) (0)
- Chapter 353 – Aspartyl Aminopeptidase (2013) (0)
- Biochemical findings in mental illness. Affective disorders (2006) (0)
- Gas chromatographic determination of dopamine and related compounds / (2017) (0)
- 1179 – DIFFERENTIAL RESPONSE OF DOPAMINERGIC STRUCTURES IN RAT BRAIN TO NEUROLEPTICS (1977) (0)
- Chapter 394 – Alanine Carboxypeptidase (2013) (0)
- 13 The Proteasome, Protein Aggregation, and Neurodegeneration (2007) (0)
- Proteases and Signaling (2005) (0)
- A MICOQUANTITATIVE TECHNIQUE FOR THE DETECTION OF SOME BIOLOGICALLY IMPORTANT AMINES BY GAS-LIQUID CHROMATOGRAPHY. (1964) (0)
- Proteasome hypofunction induces apoptosis of hippocampal granule neurons in culture:possible involvement of NFxB transcription factor (2001) (0)
- Diagnosis of pheochromocytoma. (1988) (0)
- rat DPP-IV with xanthine inhibitor 4 (2006) (0)
- Intracellular Peptide Turnover: Properties and Physiological Significance of the Major Peptide Hydrolases of Brain Cytosol (2020) (0)
- Collaborative psychopharmacologic studies exploring the major CNS metabolites of norepinephrine in psychiatrict subjects: A report of progress (1973) (0)
- Native DPP-IV (CD26) from Rat (2006) (0)
- Chapter 389 – Xaa-Arg Dipeptidase (2013) (0)
- THE EFFECTS OF METOCLOPRAMIDE AND SULPIRIDE ON DOPAMINE METABOLISM IN THE RAT BRAIN (1979) (0)
- Xaa-Arg Dipeptidase (2004) (0)
- [Strategies for identification of secretases implicated in Alzheimer's disease]. (1998) (0)
- THE DIAGNOSIS OF PHEOCHROMOCYTOMA. (1963) (0)
- Gas chromatographic determination of dopamine and related compounds / D. D. Clarke, S. Wilk, and S. E. Gitlow Chemistry Department Fordham University Bronx, New York Department of Medicine Mount Sinai Hospital New York, New York (1968) (0)
- Crystallin Reverses the Inhibition α and the Small Heat Shock Protein System in Alexander Disease Astrocytes , Protein ( GFAP ) Inhibit the Proteasome Oligomers of Mutant Glial Fibrillary Acidic Molecular Bases of Disease : (2010) (0)
- Induction of a trh degrading enzyme in gh 3 cells by triiodothyronine t 3 (1987) (0)
- rat dpp-IV with alkynyl cyanopyrrolidine #1 (2006) (0)
- Neuroleptic drugs and dopamine metabolism. (1975) (0)
- Strategies for the search of secretases in Alzheimer’s disease (1998) (0)
- Analgesic Properties and Effects on Striatal Enkephalin Levels of Inhibitors of Membrane‐Bound Metalloendopeptidase (1984) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Sherwin Wilk?
Sherwin Wilk is affiliated with the following schools:
